Develops drugs for rare diseases.
Dec 2025Revenue $180M/yrExpenses $154M/yr
No trend
Figures by year
Is Kamada profitable?
Yes. In the 12 months to Dec 2025, revenue was $180M and expenses $154M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $180M | $154M | $26.2M |
| Dec 2024 | $161M | $141M | $20.1M |
| Dec 2023 | $143M | $132M | $10.1M |
| Dec 2022 | $129M | $125M | $4.53M |
| Dec 2021 | $104M | $104M | −$696K |
| Dec 2020 | $133M | $114M | $19.2M |
| Dec 2019 | $127M | $104M | $22.8M |
| Dec 2018 | $114M | $95.2M | $19.3M |
| Dec 2017 | $103M | $95.4M | $7.44M |
| Dec 2016 | $77.5M | $83.0M | −$5.48M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.